These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 94870)

  • 1. [Clinical-experimental studies on the inhibition of thrombocyte function with acetylsalicylic acid and with indobufen].
    Vinazzer H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):783-96. PubMed ID: 94870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacology studies with indobufen (K 3920): inhibitor of platelet aggregation.
    Vinazzer H; Fuccella LM
    J Clin Pharmacol; 1980; 20(5-6 Pt 1):316-25. PubMed ID: 7400367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different patterns of inhibition of adrenaline-induced platelet aggregation and kinetics in vivo by acetylsalicylic acid and indobufen.
    Fortunato JS; Pinheiro MJ; Monteiro MC; Rodrigues MA; Amaral I
    J Int Med Res; 1991; 19(4):305-17. PubMed ID: 1916004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prostacyclin-sparing effect of indobufen vs. aspirin.
    De Caterina R; Giannessi D; Bernini W; Lazzerini G; Lavezzari M; Stragliotto E; Biagi G; Coccheri S
    Thromb Haemost; 1996 Mar; 75(3):510-4. PubMed ID: 8701417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary studies on indobufen (K 3920). A new inhibitor of platelet aggregation.
    Gürsoy AZ; Yardimci TU; Emekli NB; Ugur MS; Ulutin ON
    Haematologica; 1981 Dec; 66(6):756-67. PubMed ID: 6802717
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of acetylsalicylic acid. Dipyridamole and K 3920 on the secretion of platelet factor 4.
    Akman N
    Haematologica; 1980 Aug; 65(4):546-51. PubMed ID: 6774930
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of aspirin and indobufen in healthy volunteers.
    Lee JY; Sung KC; Choi HI
    Platelets; 2016; 27(2):105-9. PubMed ID: 26083594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of indobufen on occlusion of arteriovenous fistulas and some platelet activity in intermittent peritoneal dialysis patients.
    Dmoszyńska A; Janicki K; Janicka L; Przesmycki K; Sokołowska B; Walter-Croneck A
    Pol J Pharmacol; 1996; 48(3):327-9. PubMed ID: 9112671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory activity of indobufen (*) on platelet aggregation in vivo.
    Bergamaschi M; Pierucci L; Branzoli U
    Pharmacol Res Commun; 1984 Oct; 16(10):979-85. PubMed ID: 6438651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term effects of indobufen on several parameters of blood platelet function in subjects at thrombotic risk].
    Di Blasi S; Pintacuda S; Ferotti N; Lo Coco L; Muratore A; Russo G; Di Blasi U; D'Alessandro M; Morici G; Fornaciari M
    G Clin Med; 1990 Dec; 71(12):727-31. PubMed ID: 2150826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of 14C-labelled 2-[p-(1-oxo-2-isoindolinyl)phenyl]butyric acid, (indobufen or K 3920) in blood, platelets and platelet components.
    Vinazzer H; Zolle I; Fuccella LM; Valzelli G
    Thromb Res; 1980 Feb 1-15; 17(3-4):303-16. PubMed ID: 7368166
    [No Abstract]   [Full Text] [Related]  

  • 12. Preliminary human pharmacology studies on the inhibition of platelet aggregation by indobufen (K 3920).
    Pogliani E; Corvi G; Mandelli V; Fuccella LM
    Haematologica; 1981 Apr; 66(2):160-70. PubMed ID: 6115794
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of transdermic acetylsalicylic acid on hemostasis in healthy volunteers.
    Martínez AB; Funosas E; Maestri L; Lucena PH
    Acta Odontol Latinoam; 2007; 20(1):3-8. PubMed ID: 18046964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study between indobufen and acetylsalicylic acid on beta-thromboglobulin, platelet factor 4 and platelet aggregation in patients with transient ischemic attacks.
    Orefice G; Carrieri P; Indaco A; Iorillo L; Fioretti A
    Acta Neurol (Napoli); 1984 Apr; 6(2):97-103. PubMed ID: 6204513
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of acetylsalicylic acid on aggregation of human platelets by Porphyromonas gingivalis.
    Whitaker EJ; Thomas IS; Falk JA; Obebe A; Hammond BF
    Gen Dent; 2007; 55(1):64-9; quiz 70, 79-80. PubMed ID: 17333971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High glucose contributes to aspirin insensitivity in streptozotocin-diabetic rats: a multiparametric aggregation study.
    Watala C; Ulicna O; Golanski J; Nocun M; Waczulíková I; Markuszewski L; Drzewoski J
    Blood Coagul Fibrinolysis; 2006 Mar; 17(2):113-24. PubMed ID: 16479193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of platelet aggregation in man by indobufen (K 3920).
    Vittoria A; Laghi Pasini F; Messa GL; Di Perri T; Corvi G; Fuccella LM
    J Int Med Res; 1981; 9(1):12-7. PubMed ID: 7202826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of acetylsalicylic acid on human platelet function in vivo at salicylate steady state.
    Simrock R; Missalla A; Schwidtal P; Lischke V; Breddin HK
    Thromb Haemost; 1984 Apr; 51(2):269-71. PubMed ID: 6740559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acetylsalicylic acid (ASA) resistance in patients with ischemic heart disease (IHD) as bioindicator of the treatment strategy].
    Malý J; Pecka M; Gregor J; Dulícek P; Blazek M; Malý R; Pudil R; Bláha M
    Cas Lek Cesk; 2005; 144 Suppl 3():23-9. PubMed ID: 16335259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical contribution to the study of indobufen, a new platelet aggregation inhibitor].
    Ciammaichella A; Luzi M; Pezzi F; Recchia O
    Clin Ter; 1982 Aug; 102(4):387-95. PubMed ID: 6754219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.